Department of Nephrology, Nara Medical University, Kashihara, Japan.
Committee of Renal Data Registry, Japanese Society for Dialysis Therapy, Tokyo, Japan.
Sci Rep. 2018 Jul 3;8(1):10060. doi: 10.1038/s41598-018-28422-w.
This is a longitudinal study on 53,560 hemodialysis patients from the Japan Renal Data Registry. Predictor was D[Ca] ≥3.0 vs 2.5 mEq/L. Outcomes were the first CV events during 1-year observation period. Association of D[Ca] with CV events and effect modifications were tested using multivariate logistic regression analyses. Diabetes mellitus (DM) was a significant effect modifier for association of higher D[Ca] and myocardial infarction (MI) (OR: 1.26 (1.03-1.55) among DM and 0.86 (0.72-1.03) among non-DM, p for interaction <0.01). The effect size was not affected by further adjustment for serum albumin-corrected Ca or intact parathyroid hormone (iPTH) levels, but was attenuated by adjustment for intradialytic change in serum Ca concentration (ΔCa) (1.16 [0.89-1.51]). Among DM, D[Ca] ≥3.0 mEq/L was significantly associated with MI in the first tertile of corrected Ca or iPTH ≤60 pg/ml (p for interaction 0.03 and 0.03, respectively). In conclusion, higher D[Ca] was associated with incident MI in DM, especially with low serum Ca or iPTH levels. Attenuation of the effect size by adjustment for ΔCa and stratified analyses suggest that larger Ca influx during dialysis with higher D[Ca] in patients suggestive of low bone turnover leads to vascular calcification and subsequent MI in DM.
这是一项针对来自日本肾脏数据注册中心的 53560 名血液透析患者的纵向研究。预测因子为 D[Ca]≥3.0 与 2.5 mEq/L。结果是在 1 年观察期内发生的首次心血管事件。使用多变量逻辑回归分析测试了 D[Ca]与心血管事件的相关性及其效应修饰。糖尿病(DM)是 D[Ca]与心肌梗死(MI)相关性的显著效应修饰因子(DM 组的比值比:1.26(1.03-1.55),非 DM 组为 0.86(0.72-1.03),交互作用 P 值<0.01)。进一步校正血清白蛋白校正钙或全段甲状旁腺激素(iPTH)水平后,效应大小不受影响,但校正血清 Ca 浓度透析内变化(ΔCa)后(1.16 [0.89-1.51]),效应大小减弱。在 DM 患者中,D[Ca]≥3.0 mEq/L 与校正 Ca 第一 tertile 或 iPTH≤60 pg/ml 时的 MI 显著相关(交互作用 P 值分别为 0.03 和 0.03)。总之,较高的 D[Ca]与 DM 患者的 MI 事件相关,尤其是与低血清 Ca 或 iPTH 水平相关。通过校正 ΔCa 和分层分析减弱效应大小表明,在提示低骨转换的患者中,较高的 D[Ca]导致透析期间 Ca 内流增加,导致血管钙化和随后的 DM 患者 MI。